Physician profile
Lisandra Perez
NPI 1669855102
$1,112.52
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.75 · 2020: $160 · 2021: $275 · 2022: $368 · 2023: $109 · 2024: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $158.75 | 2021-2024 | Azstarys |
| Cumberland Pharmaceuticals, INC. | $133.83 | 2020-2022 | |
| Tris Pharma INC | $102.27 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.64 | 2021-2023 | Elaprase |
| Seqirus USA INC | $90.68 | 2021-2024 | Flucelvax, Flucelvax Quadrivalent |
| Cranial Technologies, INC | $75.92 | 2019-2023 | Doc Band |
| Pfizer INC. | $72.48 | 2020-2024 | |
| Biogen, INC. | $63.62 | 2022 | |
| Ironshore Pharmaceuticals INC. | $58.54 | 2020-2024 | |
| Kaleo, INC. | $57.69 | 2019-2022 | |
| Abbvie INC. | $54.38 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $31.17 | 2021 | |
| Adlon Therapeutics L.P. | $25.44 | 2020-2021 | |
| Sanofi Pasteur INC. | $21.59 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $19.00 | 2023 | Flumist Quadrivalent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.12 | 2024 | Gardasil 9, Gardasil, M-M-R II |
| Glaxosmithkline, LLC. | $18.09 | 2021 | |
| Dermira, INC. | $12.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisandra Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.